
CAS 1421372-66-8: AZD9291DA HCl salt
Description:AZD9291DA HCl salt, also known as Osimertinib, is a potent, selective inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase, particularly effective against certain mutations associated with non-small cell lung cancer (NSCLC). This compound is characterized by its ability to irreversibly bind to the mutant forms of EGFR, thereby inhibiting tumor growth. As a hydrochloride salt, it enhances the solubility and stability of the active pharmaceutical ingredient, facilitating its formulation for oral administration. AZD9291DA exhibits a favorable pharmacokinetic profile, with good bioavailability and a half-life that supports once-daily dosing. Its mechanism of action involves blocking downstream signaling pathways that promote cell proliferation and survival, making it a critical therapeutic option for patients with EGFR mutation-positive NSCLC. Additionally, the compound has undergone extensive clinical trials, demonstrating efficacy and a manageable safety profile, which has led to its approval for clinical use in various jurisdictions.
- Synonyms:
- Mutated EGFR-IN-1
- N1-[2-(Dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-1,2,4-benzenetriamine

N1-[2-(Dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-1,2,4-benzenetriamine
Ref: IN-DA0039E9
1g | 46.00 € | ||
5g | 93.00 € | ||
25g | 183.00 € | ||
100g | 593.00 € | ||
250mg | 26.00 € |

Mutated EGFR-IN-1
Ref: TM-T16162
25mg | 58.00 € | ||
50mg | 66.00 € | ||
100mg | 89.00 € | ||
200mg | 116.00 € | ||
500mg | 187.00 € | ||
1mL*10mM (DMSO) | 49.00 € |

N1-(2-(Dimethylamino)Ethyl)-5-Methoxy-N1-Methyl-N4-(4-(1-Methyl-1H-Indol-3-Yl)Pyrimidin-2-Yl)Benzene-1,2,4-Triamine
Ref: 54-OR1026695
1g | 32.00 € | ||
5g | 76.00 € | ||
25g | 238.00 € | ||
100g | 829.00 € |

Ref: 54-BUP15774
1g | 383.00 € | ||
50mg | 99.00 € | ||
100mg | 132.00 € | ||
200mg | 180.00 € | ||
500mg | 289.00 € |

Ref: 4Z-A-194031
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |

N1-[2-(Dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-1,2,4-benzenetriamine
Ref: 86-MM3918.01-0025
25mg | To inquire |

N1-2-(Dimethylamino) ethyl) - 5- methoxy- N1- methyl- N4- (4- (1- methyl- 1H- indol- 3- yl) pyrimidin- 2- yl) benzene- 1, 2, 4- tria mine
Ref: 3D-FD162017
1mg | Discontinued | Request information | |
2mg | Discontinued | Request information | |
5mg | Discontinued | Request information | |
100g | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information |